These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10588606)

  • 1. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease?
    Hatipoğlu U; Laghi F; Tobin MJ
    Am J Respir Crit Care Med; 1999 Dec; 160(6):1916-21. PubMed ID: 10588606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contractile properties of the human diaphragm during chronic hyperinflation.
    Similowski T; Yan S; Gauthier AP; Macklem PT; Bellemare F
    N Engl J Med; 1991 Sep; 325(13):917-23. PubMed ID: 1881417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol reduces dyspnea and improves lung function in patients with COPD.
    Ramirez-Venegas A; Ward J; Lentine T; Mahler DA
    Chest; 1997 Aug; 112(2):336-40. PubMed ID: 9266866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease.
    Cook D; Guyatt G; Wong E; Goldstein R; Bedard M; Austin P; Ramsdale H; Jaeschke R; Sears M
    Am J Respir Crit Care Med; 2001 Jan; 163(1):85-90. PubMed ID: 11208630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
    Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
    Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.
    Mahler DA; Wire P; Horstman D; Chang CN; Yates J; Fischer T; Shah T
    Am J Respir Crit Care Med; 2002 Oct; 166(8):1084-91. PubMed ID: 12379552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lung volume reduction surgery on neuromechanical coupling of the diaphragm.
    Laghi F; Jubran A; Topeli A; Fahey PJ; Garrity ER; Arcidi JM; de Pinto DJ; Edwards LC; Tobin MJ
    Am J Respir Crit Care Med; 1998 Feb; 157(2):475-83. PubMed ID: 9476861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can diaphragmatic contractility be assessed by twitch airway pressures in patients with chronic obstructive pulmonary disease?
    Topeli A; Laghi F; Tobin MJ
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1369-74. PubMed ID: 10508831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease.
    O'Donnell DE; Lam M; Webb KA
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1557-65. PubMed ID: 9817708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
    Mochizuki H; Nanjo Y; Takahashi H
    Geriatr Gerontol Int; 2013 Apr; 13(2):398-404. PubMed ID: 22817699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease.
    Taube C; Lehnigk B; Paasch K; Kirsten DK; Jörres RA; Magnussen H
    Am J Respir Crit Care Med; 2000 Jul; 162(1):216-20. PubMed ID: 10903244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lung volume reduction surgery on diaphragm strength.
    Criner G; Cordova FC; Leyenson V; Roy B; Travaline J; Sudarshan S; O'Brien G; Kuzma AM; Furukawa S
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1578-85. PubMed ID: 9603141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyspnea and inspiratory muscle function during exercise in severe chronic obstructive pulmonary disease (COPD)].
    Matsushita H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jul; 30(7):1242-9. PubMed ID: 1405099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
    Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
    Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.
    Whale CI; Sovani MP; Mortimer K; Oborne J; Cooper S; Harrison TW; Tattersfield AE
    Br J Clin Pharmacol; 2006 Aug; 62(2):153-7. PubMed ID: 16842389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.